Reported 6 months ago
The article discusses the importance of investing in dividend stocks with sustainable payouts, using Pfizer as an example of a high-yield stock that is worth holding long-term despite recent challenges. Pfizer's entry into the COVID-19 vaccine market has rejuvenated its pipeline and set a foundation for future growth, despite current financial results showing a decline in revenue and earnings. The company's forward dividend yield is over 5%, and while its cash payout ratio may seem high, management remains confident in its ability to maintain and grow dividends over time. Patience with Pfizer's recovery process is advised for long-term investors seeking income opportunities.
Source: YAHOO